Ohio has enacted a ban on synthetic kratom, a move formalized by Governor Mike DeWine through an executive order signed on December 12, 2023. This decision arises from serious concerns highlighted by the Ohio Board of Pharmacy, which warned of the substance’s potential for abuse and the associated risk of overdose deaths. The ban specifically targets synthetic variants of kratom, such as Seven-OH, which have been linked to adverse health effects.
The executive order significantly impacts local shops and consumers, mandating the immediate disposal of all synthetic kratom inventory. Businesses are now facing the challenge of adapting to this sudden change, particularly as the order serves as a precursor to a more permanent regulation expected to be proposed within six months.
Personal Stories Fuel Legislative Change
The implications of this legislative decision resonate deeply with some Ohio residents. Sisters Megan Kenney and Madison McCulloch have publicly shared their grief after losing a family member to synthetic kratom addiction. Their advocacy at the Ohio Statehouse played a crucial role in influencing this regulation. In an interview with FOX 28, Megan expressed a mix of emotions, stating, “Happy, sad, angry… I guess, a little grateful today.” Their story highlights the human cost of substance abuse, bringing a personal dimension to the policy changes.
Conversely, local businesses are voicing their concerns over the impact of this order on their operations. Jason Ingram, owner of Centuries Harvest, emphasized the potential negative effects on his livelihood, stating, “I do believe he’s going to hurt a lot of businesses.” Ingram pointed out that the kratom industry is substantial, valued at approximately $1 billion, suggesting that the ban could have far-reaching economic implications.
Regulatory Landscape and Future Actions
The timing of the executive order coincides with the upcoming holiday season, raising additional concerns for retailers who rely on kratom sales. While the ban covers synthetic versions, the sale and possession of natural kratom, which consists solely of the alkaloid mitragynine, remains legal under the current emergency rule. Nonetheless, the Ohio Board of Pharmacy is considering further regulatory measures regarding both kratom and kratom-related products, aligning with Governor DeWine’s directive.
As the situation evolves, Ohio’s actions reflect a broader trend of increasing scrutiny over substances perceived to pose health risks. The response from local communities and businesses will likely shape the discourse surrounding kratom and its future in the state. With the balance between public health and economic impact at stake, Ohio’s decision marks a pivotal moment in the ongoing conversation about substance regulation and safety.
